Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
Coupa Software (COUP) | Morgan Stanley/ J.P. Morgan/ Barclays/ RBC Capital Markets | $75.00 | n.a. | |||
CRISPR Therapeutics AG (CRSP) | Citigroup/ Piper Jaffray/ Barclays | $90.00 | n.a. | |||
Everspin Technologies (MRAM) | Stifel/ Needham & Company | $45.00 | n.a. | |||
Obalon Therapeutics (OBLN) | UBS Investment Bank/ Canaccord Genuity/ Stifel | $75.00 | n.a. | |||
Polar Power (POLA) | Roth Capital Partners/ Joseph Gunnar | 2.00 | $7.00 | $8.00 | $15.00 | n.a. |
n.a. (not available) | ||||||
Postponed | ||||||
None | ||||||
Withdrawn | ||||||
None | ||||||
New Terms | ||||||
Gridsum Holding (GSUM) | Goldman Sachs (Asia)/ Citigroup | 6.52 | $10.50 | $12.50 | $74.99 | 2-Stars |
Novan (NOVN) | Piper Jaffray | 3.75 | $11.00 | $13.00 | $45.00 | 2-Stars |
Stellar Acquisition III (STLRU) | Maxim Group LLC | 6.50 | $10.00 | $10.00 | $65.00 | 1-Star |
IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
Week of Aug. 15, 2016 | Manager(s) | Offered | Raised | Price | 8/19/16 | Change |
Stellar Acquisition III (STLRU) | Maxim Group LLC | 6.50 | $65.00 | $10.00 | $9.97 | -0.30% |